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E d i t o r i a l s 
Kidney Stones 1983: A Preventable Cause of Morbidity 
K i d n e y stones are common. The most recent data avail-
able indicate that kidney stones accounted for9.24 ou to f 
every 1,000 hospital discharges in Michigan in 1974 (1), an 
increase of 47% since 1952. Based on these data, kidney 
stones affected 13.4 out of every 10,000 persons in M ich i -
gan in 1974(1). More than 80% affect people in the 20-60 
age group, and wi th in this age group men are affected 
morethan women by a 2:1 ratio (2). It has been estimated 
that a patient who has the first stone has a 20% chance of 
a recurrence with in five years. Patients who have had 
more than one stone have an 80% chance of a further 
recurrence wi th in two years. Thus, aside f rom the health 
impact on an individual patient, kidney stones have a 
major economic impact on society, affecting otherwise 
healthy, productive members of the work force. 
Al though the first attack of acute renal colic cannot be 
predicted or prevented in most patients, data are accum-
ulating to suggest that wi th correct diagnosis and man-
agement the first attack should also be the last for most 
patients. The purpose of multidisciplinary stone clinics in 
most major academic centers is to establish an etiologic 
basis for the stone occurrence and to plan a treatment 
program that would prevent recurrence. A detailed his-
tory of the patient is the first part of this evaluation. 
Particular emphasis must be placed on the dietary history 
with respect to consumption of dairy products (calcium), 
organ meats (purines), and green leafy vegetables (oxa-
lates). The family history can provide important data 
about genetically inherited disorders associated with 
stone disease, such as absorptive hypercalciuria, gout 
and uric acid nephrolithiasis, primary hyperparathyroid-
ism, or renal tubular acidosis. Less common inherited 
disorders, such as cystinuria, are usually well known to 
the patient at the t ime of presentation. 
Knowledge of the patient's medication is an important 
source of information. Older patients who have glau-
coma treated with acetozolamide (Diamox®) often ne-
glect to include this information when they list their 
medications, but this carbonic anhydrase inhibitor affects 
urinary acidifications and reduces citrate excret ion, thus 
promot ing crystalization. A number of "stone formers" 
ingest large quantities of vitamin C, which is touted as a 
panacea for many ills. Some individuals, estimated to be 
less than 25%, metabolize ascorbic acid to oxalate. 
Patients with calcium oxalate nephrolithiasis who have 
marked increases in urine oxalate excretion should be 
questioned closely about vitamin C ingestion, either in 
tablet form or via fort i f ied orange juice or other fruit 
drinks. Another potential source of hyperoxaluria as a 
cause for calcium oxalate stones is the increased intesti-
nal absorption of oxalate in patients with inflammatory 
bowel disease or short-bowel syndrome. The physical 
chemistry of calcium and oxalate is such that small 
increments in urinary oxalate contr ibute disproport ion-
ately to the precipitability of calcium oxalate. 
Al though more than 90% of kidney stones contain cal-
c ium, only a small fraction of these are of the " t r ip le -
phosphate" (calcium, ammonium, and magnesium phos-
phate) type. This type of stones results f rom recurrent 
urinary tract infections, usually with urinary tract obstruc-
t ion , and can be identif ied by a patient's history of recur-
rent urinary tract infection and by suitable imaging 
studies. Calcium oxalate (mono- or dihydrate) thus 
accounts for most stones in all large series reported. A 
metabolic abnormality—hypercalciuria, hyperuricosuria, 
or both—can be uncovered in 60-70% of stone patients. 
The diagnosis can be firmly established by three simple 
investigations. 
Chemical analysis of the stone and its nidus, if present, 
should be performed on all stones, either those passed 
spontaneously or recovered during urologic interven-
t ion. Measuring serum calcium wil l uncover the 3-5% of 
all stone formers who have primary hyperparathyroid-
ism, and elevated serum uric acid wil l uncover a similar 
percentage of patients who have stones on this basis. 
Analysis of a 24-hour urine specimen collected while the 
patient is fo l lowing his or her usual diet (i.e., whi le the 
stone was being formed) wil l indicate the presence of 
hypercalciuria, hyperuricosuria, hyperoxaluria, or var-
ious combinations of all three. The urine volume and 
creatinine should be carefully recorded, not only to 
check the adequacy of the col lect ion, but also because 
maintenance of a high f luid volume is essential for the 
long-term management o f the stone patient. A low urine 
volume, less than 1500 ml in the first 24-hour specimen 
collected by the patient, indicates that the patient needs 
to drink more l iquid. The serum chemistry and stone 
analysis can be ordered during the initial stone attack, 
often while the patient is still hospitalized, whereas the 
24-hour urine collection should be postponed unti l the 
patient has recovered fully and has returned to his or her 
usual activities with respect to diet and f luid intake. 
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Kidney stones recur more often in patients with calcium 
nephrolithiasis who have hyperuricosuria alone or in 
combinat ion with hypercalciuria than in those patients 
who do not. The process whereby uric acid acts as a 
"seed crystal" for calcium oxalate stones has been 
termed heterogeneous nucleation. The precise mechan-
isms are poorly understood, but the process can be 
effectively eliminated by administration of 50-300 mg of 
al lopurinol daily. Of calcium stone formers, 25-35% 
exhibit this abnormality in uric acid excretion. 
Idiopathic hypercalciuria (increased urine calcium excre-
t ion in the absence of hypercalcemia) is found in about 
half of all calcium oxalate stone formers. It may be o f the 
absorptive type, in which the defect appears to be intes-
tinal hyperabsorption of calcium from the diet, or it may 
reflect a renal leak of calcium independent of dietary 
calcium absorption. Measurement of urinary calcium in 
the postabsorptive state (12-hour fast overnight) wil l dis-
tinguish between these two types of idiopathic hyper-
calciuria. The distinction is important because the com-
mon advice to restrict dairy products given to all patients 
who have a calcium-containing kidney stone is not 
appropriate to those with renal leak hypercalciuria. In 
these patients, the body stores of calcium (predomi-
nantly theskeleton) are already taxed by the renal losses 
of calcium, and restriction of dietary calcium wil l only 
serve to aggravate this condi t ion. Restricted dietary cal-
cium intake may well be appropriate for absorptive 
hypercalciuria. Thiazide diuretics (e.g., hydrochlorothia-
zide 50-100 mg per day) wil l lower the urine calcium in 
most patients independent of the pretreatment urine 
calcium and of the type of hypercalciuria. Lowering the 
urine calcium has been clearly shown to l imit the recur-
rence of kidney stones. 
Measurement of urinary, undissociated uric acid con-
centration may define a group of patients who are prone 
to form calcium oxalate stones fo l lowing seeding with 
uric acid crystals. In these patients urinary pH tends to be 
low. In about 16% of normocalciuric patients who form 
oxalate stones, the urine is oversaturated with calcium 
oxalate. Thiazide treatment appears to successfully reduce 
stone recurrence, although it may be of little value in 
patients wi thout metabolic disorders. 
The Stone Clinic at Henry Ford Hospital has only recently 
been established, but its need has already been justified 
by the rapid increase in referrals. Analysis o f t h e causes 
of stone disease in patients seen dur ing the first 12 
months of the clinic's existence indicates that a cause can 
be found for 65%. Many of these patients underwent 
their first stone evaluation in the clinic after many years 
of recurrent renal colic, during which no such evaluation 
had been performed. Our early experience confirms the 
results from other stone clinics about the preponder-
ance of men and the propor t ion of patients with the 
various etiologies for recurrent stone disease. Our follow-
up period is still too short to determine whether our 
stone clinic has been able to reduce the rate of recur-
rence of stones in our patients. 
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